Companies
China's NMPA approved etripamil nasal spray for adult PSVT. Everest owes Milestone $2.0 million.
NMPA approved etripamil nasal spray for adult PSVT — Milestone's first etripamil approval outside the U.S. — triggering a $2.0M Everest milestone. U.S. CARDAMYST status is prior FDA approval as printed, not a new FDA action.